☆Lynx1 Capital Management LP
Quality Q
0.820
AUM ($M)
866
Positions
27
Turnover
0.19
Top-10 wt
99%
Herfindahl
0.252
History (qtrs)
6
Excess Return
—
AI Eval Run AI Eval
Holdings · 29 positions · portfolio value $508M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆CGEM funds › | CULLINAN THERAPEUTICS INC | HOLD | — | 32.2% | +12.0% | 163.2 | 8,963,500 | +0 | 5 | — |
| ☆STOK funds › | STOKE THERAPEUTICS INC | TRIM | — | 26.0% | +1.5% | 132.1 | 4,038,404 | -725,269 | 5 | — |
| ☆AGIO funds › | AGIOS PHARMACEUTICALS INC | ADD | — | 24.9% | +11.0% | 126.5 | 3,408,937 | +797,369 | 3 | — |
| ☆CCCC funds › | C4 THERAPEUTICS INC | ADD | — | 6.7% | +3.8% | 34.2 | 7,326,691 | +327,789 | 5 | — |
| ☆KRRO funds › | KORRO BIO INC | HOLD | — | 4.0% | +1.2% | 20.3 | 1,538,296 | +0 | 3 | — |
| ☆TCRX funds › | TSCAN THERAPEUTICS INC | HOLD | — | 1.5% | +0.3% | 7.9 | 8,019,148 | +0 | 5 | — |
| ☆DTIL funds › | PRECISION BIOSCIENCES INC | TRIM | — | 1.5% | +0.6% | 7.5 | 950,466 | -34,647 | 5 | — |
| ☆NEUP funds › | NEUPHORIA THERAPEUTICS INC | HOLD | — | 0.8% | +0.2% | 3.8 | 875,328 | +0 | 3 | — |
| ☆PASG funds › | PASSAGE BIO INC | ADD | — | 0.6% | -0.1% | 3.3 | 673,759 | +50,055 | 4 | — |
| ☆CGON funds › | CG ONCOLOGY INC | TRIM | — | 0.4% | +0.1% | 2.2 | 31,391 | -200 | 3 | — |
| ☆PLRX funds › | PLIANT THERAPEUTICS INC | NEW | — | 0.4% | +0.4% | 2.0 | 1,798,070 | +1,798,070 | 1 | — |
| ☆TRDA funds › | ENTRADA THERAPEUTICS INC | TRIM | — | 0.3% | -0.2% | 1.3 | 178,606 | -33,083 | 3 | — |
| ☆VYNE funds › | VYNE THERAPEUTICS INC | HOLD | — | 0.2% | +0.1% | 1.1 | 1,628,700 | +0 | 2 | — |
| ☆TRAW funds › | TRAWS PHARMA INC | ADD | — | 0.1% | +0.1% | 0.5 | 559,470 | +544,392 | 2 | — |
| ☆FHTX funds › | FOGHORN THERAPEUTICS INC | NEW | — | 0.1% | +0.1% | 0.3 | 61,588 | +61,588 | 1 | — |
| ☆DNLI funds › | DENALI THERAPEUTICS INC | TRIM | — | 0.1% | -5.6% | 0.3 | 11,658 | -1,868,645 | 4 | — |
| ☆XNCR funds › | XENCOR INC | TRIM | — | 0.1% | -1.0% | 0.3 | 18,194 | -518,204 | 3 | — |
| ☆HOWL funds › | WEREWOLF THERAPEUTICS INC | HOLD | — | 0.0% | -0.0% | 0.2 | 657,786 | +0 | 3 | — |
| ☆AVTX funds › | AVALO THERAPEUTICS INC | NEW | — | 0.0% | +0.0% | 0.2 | 10,100 | +10,100 | 1 | — |
| ☆CUSIP:097702203 funds › | BOLT BIOTHERAPEUTICS INC | HOLD | — | 0.0% | +0.0% | 0.1 | 30,800 | +0 | 2 | — |
| ☆NUVB funds › | NUVATION BIO INC | NEW | — | 0.0% | +0.0% | 0.1 | 16,029 | +16,029 | 1 | — |
| ☆EPRX funds › | EUPRAXIA PHARMACEUTICALS INC | NEW | — | 0.0% | +0.0% | 0.1 | 10,000 | +10,000 | 1 | — |
| ☆IKT funds › | INHIBIKASE THERAPEUTICS INC | NEW | — | 0.0% | +0.0% | 0.0 | 20,000 | +20,000 | 1 | — |
| ☆ABSI funds › | ABSCI CORPORATION | EXIT | Common Stock | 0.0% | -0.0% | 0.0 | 0 | -21,245 | 0 | — |
| ☆DSGN funds › | DESIGN THERAPEUTICS INC | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -119,516 | 0 | — |
| ☆IBIO funds › | IBIO INC | EXIT | — | 0.0% | -0.0% | 0.0 | 0 | -68,076 | 0 | — |
| ☆PRQR funds › | PROQR THRAPEUTICS N V | EXIT | — | 0.0% | -0.0% | 0.0 | 0 | -68,486 | 0 | — |
| ☆GHRS funds › | GH RESEARCH PLC | EXIT | — | 0.0% | -23.9% | 0.0 | 0 | -10,763,288 | 0 | — |
| ☆IMTX funds › | IMMATICS N.V | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -216,973 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 508 | 23 | 0.31 | 99% | 0.240 | 0.534 | — | in |
| 2026Q1 | 633 | 23 | 0.17 | 97% | 0.183 | 0.812 | — | in |
| 2025Q4 | 494 | 22 | 0.42 | 97% | 0.233 | 0.265 | — | in |
| 2025Q3 | 491 | 14 | 0.13 | 99% | 0.198 | 0.821 | — | in |
| 2025Q2 | 346 | 15 | 0.07 | 99% | 0.171 | 0.880 | — | entered |
| 2025Q1 | 279 | 14 | 0.00 | 98% | 0.166 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status